PharmTech Drug Digest 11.20
News|Articles|March 12, 2014

Almac Expands Asia Pacific Operations

Author(s)Melanie Sena

Almac expands technical, project, and operational resources in Asia.

Almac

reported the expansion of its clinical services and technologies capabilities to include technical, project, and operational resources in Asia. The company has established regional hubs in Singapore and Japan to improve the need to conduct clinical trials in Asia and manage global trials from the region.

As part of the expansion, Almac is building a new secondary packaging facility in Singapore, which is expected to open by the end of 2014.

Source:

Almac


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.